Document is current
Any future updates will be listed below
-
Authors
Donado, Carlos A. https://orcid.org/0000-0002-1093-3088
Theisen, Erin https://orcid.org/0000-0003-1864-0594
Zhang, Fan https://orcid.org/0000-0002-6102-2970
Nathan, Aparna https://orcid.org/0000-0002-5975-2851
Fairfield, Madison L.
Rupani, Karishma Vijay https://orcid.org/0000-0002-4779-8326
Jones, Dominique
Johannes, Kellsey P.
,
Albrecht, Jennifer
Anolik, Jennifer H.
Apruzzese, William
Barnas, Jennifer L.
Bathon, Joan M.
Ben-Artzi, Ami
Boyce, Brendan F.
Boyle, David L.
Bridges, S. Louis Jr
Bykerk, Vivian P.
Campbell, Debbie
Ceponis, Arnold
Chicoine, Adam
Curtis, Michelle
Deane, Kevin D.
DiCarlo, Edward
Donlin, Laura T.
Dunn, Patrick
Filer, Andrew
Carr, Hayley
Firestein, Gary S.
Forbess, Lindsy
Geraldino-Pardilla, Laura
Goodman, Susan M.
Gravallese, Ellen M.
Rao, Deepak
Gregersen, Peter K.
Guthridge, Joel M.
Gutierrez-Arcelus, Maria
Holers, V. Michael
Horowitz, Diane
Hughes, Laura B.
Ivashkiv, Lionel B.
Ishigaki, Kazuyoshi
James, Judith A.
Kang, Joyce B.
Keras, Gregory
Lakhanpal, Amit
Lederer, James A.
Lewis, Miles J.
Li, Yuhong
Liao, Katherine
Mandelin, Arthur M. II
Mantel, Ian
Marks, Kathryne E.
Maybury, Mark
McDavid, Andrew
McGeachy, Mandy J.
Mears, Joseph R.
Meednu, Nida
Millard, Nghia
Moreland, Larry
Nayar, Saba
Nerviani, Alessandra
Orange, Dana E.
Perlman, Harris
Pitzalis, Costantino
Rangel-Moreno, Javier
Raza, Karim
Reshef, Yakir
Ritchlin, Christopher
Rivellese, Felice
Robinson, William H.
Rumker, Laurie
Sahbudin, Ilfita
Sakaue, Saori
Seifert, Jennifer A.
Scheel-Toellner, Dagmar
Singaraju, Anvita
Slowikowski, Kamil
Smith, Melanie
Tabechian, Darren
Utz, Paul J.
Weinand, Kathryn
Weisenfeld, Dana
Weisman, Michael H.
Xiao, Qian
Zhu, Zhu
Li, Zhihan J.
Cordle, Andrew
Wyse, Aaron
Raychaudhuri, Soumya https://orcid.org/0000-0002-1901-8265
Dwyer, Daniel F.
Jonsson, A. Helena https://orcid.org/0000-0002-9558-2474
Brenner, Michael B. https://orcid.org/0000-0001-6202-8445
- License Information
-
More Information
Article History
Received: 12 July 2023
Accepted: 29 January 2025
First Online: 6 February 2025
Competing interests
: M.B.B. is a consultant to GSK, Third Rock Ventures, 4FO Ventures and Moderna and a consultant to and founder of Mestag Therapeutics. S.R. is a founder of Mestag Therapeutics, a scientific adviser for Janssen and Pfizer, and a consultant to Gilead and Rheos Medicine. D.F.D. is a consultant to Celldex Therapeutics. The remaining authors declare no competing interests.
